Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

People With Hypochondriasis Face Increased Risk Of Death From Natural, Unnatural Causes, Study Finds

The AP (12/13, Johnson) reports “a large Swedish study has” found that people with hypochondriasis “tend to die earlier than people who aren’t hypervigilant about health concerns.” The study “found that people with the diagnosis have an increased risk of death from both natural and unnatural causes, particularly suicide.”

Chronic stress and its effect “on the body could explain some of the difference, the authors wrote.” Dr. Jonathan E. Alpert, “who leads the American Psychiatric Association’s council on research,” said, “It takes a great deal of respect and sensitivity conveyed to patients that this itself is a kind of condition, that it has a name. … And, fortunately, there are good treatments.” The findings were published in JAMA Psychiatry.

MedPage Today (12/13, DePeau-Wilson) also reports on the study.

Related Links:

— “In hypochondria paradox, Swedish study finds a higher death rate in those who fear serious illness,” Carla K. Johnson, Associated Press, December 13, 2023

USPSTF recommends children with obesity receive intensive counseling starting at age six

Reuters (12/12, Lapid) reports, “Children with obesity should receive intensive counseling to promote healthy diet and exercise habits starting at age 6, according to a draft recommendation” issued by the U.S. Preventive Services Task Force on Wednesday. In 2017, the USPSTF “had recommended … that screening for obesity start at age 6.” However, “research since then has shown the effectiveness of intensive behavioral interventions … for achieving a healthy weight and improving the quality of life for children and adolescents, the panel said.”

CNN (12/12, Christensen) reports, “The task force’s draft recommendations do not include weight loss medications or surgery, although it has looked at some research on those interventions.”

Related Links:

— “US panel recommends children with obesity start counseling from age 6,” Nancy Lapid, Reuters, December 12, 2023

Gun Violence In US Likely Driven By High Number Of Available Firearms, Study Suggests

HealthDay (12/12, Thompson) reports “gun advocates often claim that mental illness is the driving force behind mass shootings in the United States,” but a new study “argues that gun violence is more likely driven by the massive numbers of firearms available throughout the country, providing easy access.” The findingswere published in the American Journal of Medicine.

Related Links:

— “Firearm Access Drives High Rate of U.S. Gun Deaths, International Study Finds,” Dennis Thompson, HealthDay, December 12, 2023

Isotretinoin (Accutane) Not Linked To Increased Risk For Suicide Or Psychiatric Conditions, Study Suggests

Healio (12/12, Capaldo) reports, “Isotretinoin is not associated with an increased risk for suicide or psychiatric conditions on a population level, according to a study.” The researchers found “isotretinoin use was associated with a lower risk of suicide attempt at 2 to 4 years following treatment.” The findings were published in JAMA Dermatology.

Related Links:

— “Isotretinoin not associated with increased risk for suicide, psychiatric conditions,” Gabrielle Capaldo, Healio, December 12, 2023

Cannabis-Based Medicinal Products Linked To Improving Anxiety, Quality Of Life In Patients With AD/HD, Study Suggests

HCPlive (12/11, Derman) reports, “Cannabis-based medicinal products (CBMPs) are associated with improving anxiety, sleep quality, and health-related quality of life in patients with” AD/HD, “according to a new study.” The research found that “with the CBMP treatment, less patients had to take concomitant” AD/HD “medication, with a reduction of 38.46% in lisdexamfetamine, 15% in methylphenidate, and 14.29% in dexamfetamine.” The findings were published in Neuropsychopharmacology Reports.

Related Links:

— “Cannabis Treatment Linked to Improving Quality of Life in ADHD Patients,” Chelsie Derman, HCPLive, December 11, 2023

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.